Beta-blockers in heart failure patients with severe chronic kidney disease—time for a randomized controlled trial?
| dc.contributor.author | Agarwa, Rajiv | |
| dc.contributor.author | Rossignol, Patrick | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2020-07-29T21:22:59Z | |
| dc.date.available | 2020-07-29T21:22:59Z | |
| dc.date.issued | 2019-10-03 | |
| dc.eprint.version | Final published version | en_US |
| dc.identifier.citation | Agarwal, R., & Rossignol, P. (2020). Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 35(5), 728–731. https://doi.org/10.1093/ndt/gfz187 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/23426 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Oxford University Press | en_US |
| dc.relation.isversionof | 10.1093/ndt/gfz187 | en_US |
| dc.relation.journal | Nephrology, Dialysis, Transplantation | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Beta-blockers | en_US |
| dc.subject | Kidney failure | en_US |
| dc.subject | Chronic heart failure | en_US |
| dc.title | Beta-blockers in heart failure patients with severe chronic kidney disease—time for a randomized controlled trial? | en_US |
| dc.type | Article | en_US |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203559/ | en_US |